Jason Child
Analyst · Morgan Stanley. Please go ahead
Thank you, Rene. Q3 was another record quarter, as we continue to deliver strong growth. Total revenue was $983 million, which was above the top-end of our guided range. Royalty revenue was a record $580 million and grew 23% year-on-year and was above our expectations. This growth was driven by continued Armv9 adoption and initial shipments of chips based on our compute subsystems, as well as the growth in revenues from silicon -- custom silicon going into the data center. Royalty revenue from chips for smartphones, the data center, networking equipment and automotive, were all within expectations, while royalty revenue from IoT showed signs of recovery after multiple quarters of weakness. Based on the most recent royalty reports, revenues from smartphones continue to grow much faster than the overall smartphone market. This was helped by chips based on both Armv9 and CSS, such as MediaTek's Dimensity 9400, which is being deployed in flagship smartphones from both Oppo and Vivo. Licensing revenue increased 14% year-on-year to $403 million, which was better than we forecasted. License revenue varies quarter-to-quarter due to normal fluctuations in timing and size of multiple high-value license agreements and contributions from backlog. As always, we recommend that you look at annualized contract value, or ACV, to best understand the underlying licensing growth rate. ACV in Q3 was up 9% year-on-year, which was a little lower than the recent run-rate of low-teens, but is above our long-term plan. Remaining performance obligations, or RPO, was down slightly sequentially, as Arm delivered products that released revenue from backlog into the P&L. As you know, Arm's revenues today come from technology developed years or even decades ago, and our costs today are investments for future revenue streams. To maximize our future revenue opportunity, we want to maximize our investment in R&D today. And in the third quarter, heightened R&D spending led our non-GAAP operating costs to their highest-level at $522 million, which was in-line with our expectations. At the same time, we also delivered near-record levels of non-GAAP operating profit at $442 million. Going forward, we will continue to balance increasing investments for the long-term growth of the business and near-term profitability. Turning now to guidance, I'll briefly touch on both fourth quarter and fiscal year ending March 31, 2025. This guidance reflects our current view of our end-markets and our licensing pipeline. For Q4, we expect revenue of between $1.175 billion and $1.275 billion. At the midpoint, this represents revenue growth of 32% year-on-year. We have left the revenue guidance range slightly wider than in prior quarters, as we have some large licensed deals in play. Although we have high confidence of deal closure, the timing of deals can be hard to forecast and some may slip into the next fiscal year. As previously mentioned, revenue growth today enables us to increase our investments in the R&D essential for our long-term success. We are accelerating the investments in our next-generation of technologies. We now expect our Q4 non-GAAP operating expense to be approximately $590 million, and for Q4, we expect non-GAAP EPS to be in the range of $0.48 to $0.56. For fiscal year '25, we are increasing the midpoint of full-year guidance to around $4 billion. This midpoint represents about a 24% year-on-year growth, which is ahead of our long-term target of 20%. With this, we expect full-year royalty revenue growth rate in the high-teens year-on-year, which is consistent with our previous guidance. We expect our full-year license revenue to grow around 30% year-on-year. We expect non-GAAP operating expenses to be about $2.1 billion, which represents a 21% year-on-year increase. We therefore expect our full-year non-GAAP EPS to be between $1.56 and $1.64. With that, I will turn the call back to the operator for the Q&A portion of the call.